Patents-Review.com
ClassID:

116811 ⎘

C12Y304/19012 - CPC Classification

Classification description:

Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Omega peptidases (3.4.19) Ubiquitinyl hydrolase 1 (3.4.19.12)

Recent Application in this class:
#1
20240335554
2024-10-10

POST-TRANSLATIONAL MODIFICATION CHIMERIC MOLECULE

 #2
20240026330
2024-01-25

MITOCHONDRIAL PROTEIN TARGETING ENGINEERED DEUBIQUITINASES AND METHODS OF USE THEREOF

 #3
20240026329
2024-01-25

NUCLEAR PROTEIN TARGETING DEUBIQUITINASES AND METHODS OF USE

 #4
20240025984
2024-01-25

CYTOSOLIC PROTEIN TARGETING DEUBIQUITINASES AND METHODS OF USE

 #5
20230203485
2023-06-29

METHODS FOR MODULATING MHC-I EXPRESSION AND IMMUNOTHERAPY USES THEREOF

 #6
20230122801
2023-04-20

USP10 TARGETED SELF-DELIVERABLE SIRNA COMPOSITIONS AND METHODS FOR PREVENTING OR INHIBITING FIBROSIS AND/OR SCARRING

 #7
20230040829
2023-02-09

COMPOSITIONS AND METHODS FOR MODULATING ATAXIN 3 EXPRESSION

 #8
20220175895
2022-06-09

Method for preventing or treating metabolic disorder

 #9
20220056536
2022-02-24

Methods of modulating immune response

 #10
20220025349
2022-01-27

COMPOSITIONS AND METHODS FOR TREATING CANCER

 #11
20220017960
2022-01-20

INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF

 #12
20210318329
2021-10-14

Sensors and assays for ubiquitin or ubiquitin-like proteins

 #13
20210047657
2021-02-18

METHODS OF AAV VECTOR PRODUCTION BY MODULATING DEUBIQUITINATING ENZYME ACTIVITY

 #14
20210017532
2021-01-21

Methods for increasing grain productivity

 #15
20200332298
2020-10-22

ANTISENSE OLIGONUCLEOTIDE DIRECTED REMOVAL OF PROTEOLYTIC CLEAVAGE SITES FROM PROTEINS

 #16
20200325473
2020-10-15

Compositions and methods for modulating Ataxin 3 expression

 #17
20200224203
2020-07-16

ANTISENSE OLIGONUCLEOTIDE DIRECTED REMOVAL OF PROTEOLYTIC CLEAVAGE SITES, THE HCHWA-D MUTATION, AND TRINUCLEOTIDE REPEAT EXPANSIONS

 #18
20200172911
2020-06-04

USP30 INHIBITORS AND METHODS OF USE

 #19
20200003789
2020-01-02

Neural proteins as biomarkers for nervous system injury and other neural disorders

 #20
20190346453
2019-11-14

Sensors and assays for ubiquitin or ubiquitin-like proteins

 #21
20190105341
2019-04-11

Compositions and Methods for Treating Alzheimer's Disease and Other Tauopathies

 #22
20190062697
2019-02-28

Cell Differentiation Marker and its Uses

 #23
20190030139
2019-01-31

USP10 MODULATION OF AMPK AND MTOR

 #24
20180364250
2018-12-20

Sensors and assays for ubiquitin or ubiquitin-like proteins

 #25
20180291380
2018-10-11

USP30 INHIBITORS AND METHODS OF USE

 #26
20180258425
2018-09-13

Compositions and methods for modulating Ataxin 3 expression

 #27
20170298359
2017-10-19

Oligonucleotide targeted to the A20-3′ untranslated region

 #28
20170269091
2017-09-21

Method and treatment of recurring endometrial cancer with an inhibitor of USP14

 #29
20170226521
2017-08-10

Antisense oligonucleotide directed removal of proteolytic cleavage sites, the HCHWA-D mutation, and trinucleotide repeat expansions

 #30
20170175117
2017-06-22

Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins

 #31
20170072071
2017-03-16

INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF

 #32
20160264933
2016-09-15

CELL DIFFERENTIATION MARKER AND ITS USES

 #33
20160151407
2016-06-02

Compositions and methods for treating alzheimer's disease and other tauopathies

 #34
20160031957
2016-02-04

Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

 #35
20150065561
2015-03-05

Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD

 #36
20140322725
2014-10-30

Sensors and assays for ubiquitin or ubiquitin-like proteins

 #37
20130065273
2013-03-14

Engineered E2 for increasing the content of free LYS11-linked ubiquitin

 #38
20120145544
2012-06-14

Ubiquitin ligase and use thereof

 #39
20110177974
2011-07-21

Neural proteins as biomarkers for nervous system injury and other neural disorders

 #40
20100317041
2010-12-16

Neural proteins as biomarkers for nervous system injury and other neural disorders